| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Eur J Cardiothorac Surg 2006;29:268
© 2006 Elsevier Science NL
Letter to the Editor |
a Department of Surgery, Thoracic Division, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
b Institute of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan, ROC.
Received 27 September 2005; accepted 31 October 2005.
* Corresponding author. Tel.: +886 6 2353535 5187; fax: +886 6 2766676. (Email: tsengyl{at}mail.ncku.edu.tw).
Key Words: Thymoma • Recurrence • Postoperative myasthenia gravis
We have read the article by Kondo and Monden [1] with great interest. In our institution, post-thymectomy myasthenia gravis (MG) occurred in 2 of 91 patients (2%) with thymic epithelial tumors, previously diagnosed without MG (from June 1988 to June 2004). The incidence is similar to the findings of Namba et al. [2] and Ito et al. [3]. Previously, we reported a patient with thymic carcinoid who developed MG 31 days after thymomectomy [4]. Now, this patient who has been followed for 40 months has been in a state of complete remission from MG for 12 months. In this letter, we would like to share a rare experience about a patient who developed MG 30 months after resection of recurrent thymoma.
A 43-year-old man with an incidental finding of a mediastinal tumor on his chest X-ray underwent complete thymomectomy because of stage IIb (Masaoka stage) thymoma (WHO type B1) on November 25, 1980. Although postoperative mediastinal radiation treatment (4500 cGy) was given, the tumor recurred in the right pleural cavity, necessitating a pleurectomy, partial diaphragmatic resection and right lower lobe lobectomy 35 months later. After the second operation, he received adjuvant chemoradiation therapy, including six applications of cisplatin-based chemotherapy and radiotherapy of the right chest cavity (total dose of 5040 cGy). Thirty months after the second operation, he developed a general type of MG and was placed under pyridostigmine and steroid therapy. Although no recurrence of thymoma in this patient was found, he eventually died from pulmonary tuberculosis in February 1990. At that time he still required a full dose of pyridostigmine and steroids to control the MG.
The interval between thymomectomy and the onset of postoperative MG varies. Ito et al. [3] divided post-thymectomy MG into early- and late-onset types. Namba et al. [2] reported that patients with a shorter onset of postoperative MG had a better prognosis, but both Kondo's and Ito's studies did not find this tendency. Our results, although limited, support Namba's findings. Ito et al. [3] ever reported five patients who had a delayed type of postoperative MG confirmed on thymoma recurrence. As mentioned in this letter, our patient showed that, after resection of recurrent thymoma, there is still a chance of developing late-onset type of postoperative MG.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
